Meet the next-generation approach to cancer treatment. 💊🌟 Switchable CAR-T (sCAR-T) is a programmable immunotherapy designed to give scientists and clinicians greater control over how—and when—the immune system attacks cancer. This modular CAR-T platform activates engineered

A paper in Nature presents OpenScholar, an open-source language model that can outperform commercial large language models (LLMs) in performing accurate literature reviews. go.nature.com/3M66wXe

Osimertinib disrupts the MYLK4–CDKAL1 interaction suppresses CDKAL1-dependent SALL2 translation, resulting in impaired Cancer Stem Cell maintenance and enhanced chemosensitivity in Rhabdomyosarcoma.

Pope Leo XIV in a very practical Lenten Message to all Christians says: “I would like to invite you to a very practical and frequently unappreciated form of abstinence: that of refraining from words that offend and hurt our neighbor. Let us begin by disarming our language,

In appreciation of her transformative global leadership in precision oncology and her respect for the human life of every cancer patient, I presented Dr. Sewanti Limaye 🇮🇳🇺🇸 with the Proceedings of the last WIN Symposium in which she participated. Dr. Limaye was elected Vice Chair of

Cancer changes. Your treatment should too. Too many of our loved ones have been treated with a plan made on Day 1, even when their tumor evolves, resists, and outsmarts that plan by month three. (1/2)

ADAPT trials will track tumors in real-time — testing, anticipating resistance, and adjusting. Enrollment now open for patients with metastatic breast or lung cancer. (2/2) arpa-h.gov/news-and-event…

Stanford and Caltech researchers just published the first comprehensive taxonomy of how llms fail at reasoning not a list of cherry-picked gotchas. a 2-axis framework that finally lets you compare failure modes across tasks instead of treating each one as a random anecdote the

Nacresertib newdrugapprovals.org/2026/02/15/nac… via Anthony M Crasto DR.

A person's mental health in the year after they receive a cancer diagnosis may impact how long they survive. Cancer Today rounds up the week's top stories in cancer research and care.

Former President Joe Biden: "Did you see Trump give the State of the Union...? Is he still talking? It's unbelievable, the guy talks almost two hours but never mentions the anniversary of Putin invading Ukraine. Never once."

Democrats will let Trump send your children to die if it's politically convenient for them in the midterms. They are not going to stop Trump. They are not going to save you. They're not even gonna try. Vote Libertarian.

On the topic of Iran

🧠 PMWC 2026, March 5, S1, Santa Clara Convention Center, California Alexander G. Lai, will give a talk of VincoAI and VincoPath in the Precision Medicine World Conference (PMWC) 2026. 📍 Santa Clara Convention Center, California 📅 March 5, 2026, S1 (1:00PM) #Vincogen #PMWC2026

#ThrowbackTuesday The best ideas won’t stay in the lab. ARPA-H Dr. Alicia Jackson visited her alma mater Massachusetts Institute of Technology (MIT) to meet PhD innovators pushing science that didn’t exist a few years ago. Thanks, MIT!

For too long, the lymphatic system has been invisible in medicine. The day before #WorldLymphedemaDay (March 5), join us for “From Invisible to Invincible”— a community conversation about making lymphatic health visible, treatable & preventable. Register: solutions.arpa-h.gov/Events/LIGHT/

A child’s chance of surviving cancer shouldn’t depend on their ZIP code. PCX is building secure, AI-powered data sharing across 200+ pediatric centers — designed with family and clinician input from day one. arpa-h.gov/news-and-event…

6. Portfolio of IP Assets pharmaceuticalintelligence.com/2026-beyond-ma… via @pharma_BI Aviva Lev-Ari Stephen J Williams I wanted to share the **2026 & Beyond Master Plan** for LPBI Group — a 9 GB private multimodal corpus + proprietary COM Tool Factory designed specifically for AI in drug discovery and

A tumor-derived metabolite primes the leptomeningeal pre-metastatic niche nature.com/articles/s4301…

Pope Leo says he has "no fear of the Trump administration" after he was asked about President Trump's Truth Social post calling the pontiff "weak on crime, and terrible for foreign policy." "We are not politicians, we don't deal with foreign policy with the same perspective he